These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy. Channon KM; Qian H; George SE Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1873-81. PubMed ID: 10938006 [TBL] [Abstract][Full Text] [Related]
3. Adventitial gene transfer to arterial wall. Laitinen M; Ylä-Herttuala S Pharmacol Res; 1998 Apr; 37(4):251-4. PubMed ID: 9634639 [TBL] [Abstract][Full Text] [Related]
4. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. French BA; Mazur W; Ali NM; Geske RS; Finnigan JP; Rodgers GP; Roberts R; Raizner AE Circulation; 1994 Nov; 90(5):2402-13. PubMed ID: 7955199 [TBL] [Abstract][Full Text] [Related]
5. Effect of adenoviral titer and instillation pressure on gene transfer efficiency to arterial and venous grafts ex-vivo. Brevetti LS; Chang DS; Sarkar R; Messina LM J Vasc Surg; 2002 Aug; 36(2):263-70. PubMed ID: 12170198 [TBL] [Abstract][Full Text] [Related]
13. Vascular gene transfer for the treatment of restenosis and atherosclerosis. Laitinen M; Ylä-Herttuala S Curr Opin Lipidol; 1998 Oct; 9(5):465-9. PubMed ID: 9812201 [TBL] [Abstract][Full Text] [Related]
14. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. von der Leyen HE; Gibbons GH; Morishita R; Lewis NP; Zhang L; Nakajima M; Kaneda Y; Cooke JP; Dzau VJ Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1137-41. PubMed ID: 7532305 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy for cardiovascular disease: a case for cautious optimism. Khurana R; Martin JF; Zachary I Hypertension; 2001 Nov; 38(5):1210-6. PubMed ID: 11711525 [TBL] [Abstract][Full Text] [Related]
16. Gene transfer to the vascular system: Novel translational perspectives for vascular diseases. Remes A; Basha DI; Frey N; Wagner AH; Müller OJ Biochem Pharmacol; 2020 Dec; 182():114265. PubMed ID: 33035508 [TBL] [Abstract][Full Text] [Related]
17. Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. Shears LL; Kibbe MR; Murdock AD; Billiar TR; Lizonova A; Kovesdi I; Watkins SC; Tzeng E J Am Coll Surg; 1998 Sep; 187(3):295-306. PubMed ID: 9740187 [TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Chen SJ; Wilson JM; Muller DW Circulation; 1994 May; 89(5):1922-8. PubMed ID: 7514108 [TBL] [Abstract][Full Text] [Related]
19. Gene-eluting stents: non-viral, liposome-based gene delivery of eNOS to the blood vessel wall in vivo results in enhanced endothelialization but does not reduce restenosis in a hypercholesterolemic model. Sharif F; Hynes SO; McCullagh KJ; Ganley S; Greiser U; McHugh P; Crowley J; Barry F; O'Brien T Gene Ther; 2012 Mar; 19(3):321-8. PubMed ID: 21716298 [TBL] [Abstract][Full Text] [Related]
20. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Walter DH; Cejna M; Diaz-Sandoval L; Willis S; Kirkwood L; Stratford PW; Tietz AB; Kirchmair R; Silver M; Curry C; Wecker A; Yoon YS; Heidenreich R; Hanley A; Kearney M; Tio FO; Kuenzler P; Isner JM; Losordo DW Circulation; 2004 Jul; 110(1):36-45. PubMed ID: 15210598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]